Microalbuminuria: A Genetic Link Between Diabetes and Cardiovascular Disease?

References

• Jarrett R J. Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease: chicken, egg or neither?. Diabetologia 1984; 26: 99–102
   PubMed Web of Science ®Google Scholar
• Nelson R G., Sievers M L., Knowler W C., et al. Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation 1990; 81: 987–95
   PubMed Web of Science ®Google Scholar
• Herman J B., Medalie J H., Goldbourt U. Differences in cardiovascular mobidity and mortality between previously known and newly diagnosed adult diabetics. Diabetologia 1977; 13: 229–34
   PubMed Web of Science ®Google Scholar
• Haffner S M., Stern M P., Hazuda H P., Mitchell B D., Patterson J K. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes. JAMA 1990; 263: 2893–8
   PubMed Web of Science ®Google Scholar
• Fuller J H., Shipley M J., Rose G, Jarrett R J., Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall Study. Br Med J 1983; 287: 867–70
   PubMed Web of Science ®Google Scholar
• Vaccaro O, Stamler J, Neaton J, Wentworth D. Ten-year CHD mortality in men screened for the Multiple Risk Factor Intervention Trial: role of diabetes and other cardiovascular factors. Proceedings of the 26th Annual Meeting of the European Diabetes Epidemiology Study Group, Lund, Sweden, May, 1991
   Google Scholar
• Reaven G M. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607
   PubMed Web of Science ®Google Scholar
• Borch-Johnsen K, Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. Br Med J 1987; 294: 1651–54
   PubMed Web of Science ®Google Scholar
• Jarrett R J., Viberti G C., Argyropoulos A, et al. Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med 1984; 1: 17–9
   PubMedGoogle Scholar
• Mogensen C E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356–60
   PubMed Web of Science ®Google Scholar
• Schmitz A, Vaeth M. Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabetic Med 1988; 5: 126–34
   PubMed Web of Science ®Google Scholar
• Mattock M B., Keen H, Viberti G C., et al. Coronary heart disease and urinary albumin excretion rate in Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1988; 31: 82–7
   PubMed Web of Science ®Google Scholar
• Jensen T, Stender S, Deckert T. Abnormalities in plasma concentrations of lipoproteins and fibrinogen in type I (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia 1988; 31: 142–5
   PubMed Web of Science ®Google Scholar
• Collins V R., Dowse G K., Finch C F., Zimmet P Z., Linnane A W. Prevalence and risk factors for micro- and macro-albuminuria in diabetic subjects and entire population of Nauru. Diabetes 1989; 38: 1602–10
   Google Scholar
• Gough S CL, McCormack L, Chapman C, Rice P J., Grant P J. The relationship between insulin resistance, diastolic blood pressure, urinary albumin concentration and fibrinolytic activity in patients with type 2 diabetes mellitus. Clin Sci 1991; 81(Suppl. 26)5P
   Google Scholar
• Yudkin J S., Forrest R D., Jackson C A. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 1988; ii: 530–3
   Google Scholar
• Damsgaard E M., Frøland A, Jørgensen O D., Mogensen C E. Eight to nine year mortality in known non-insulin dependent diabetics and controls. Kidney Int 1992; 41: 731–5
   PubMedGoogle Scholar
• Haffner S M., Stern M P., Gruber M KK, et al. Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects?. Arteriosclerosis 1990; 10: 727–31
   Google Scholar
• Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno Hypothesis. Diabetologia 1989; 32: 219–26
   PubMed Web of Science ®Google Scholar
• Jenkins A J., Steele J S., Janus E D., Best J D. Increased plasma apolipoprotein(a) levels in IDDM patients with microalbuminuria. Diabetes 1991; 40: 787–90
   PubMed Web of Science ®Google Scholar
• Boerwinkle E, Menzel H J., Kraft H G., Utermann G. Genetics of the quantitative Lp(a) lipoprotein trait: III. Contribution of Lp(a) glycoprotein phenotypes to normal lipid variation. Hum Genet 1989; 82: 73–8
   PubMed Web of Science ®Google Scholar
• Krolewski A S., Canessa M, Warram J H., et al. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988; 318: 140–5
   PubMed Web of Science ®Google Scholar
• Mangili R, Bending J J., Scott G, et al. Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1988; 318: 146–50
   PubMedGoogle Scholar
• Dadone M M., Hasstedt S J., Hunt S C., et al. Genetic analysis of sodium-lithium countertransport in 10 hypertension-prone kindreds. Am J Med Genet 1984; 17: 565–77
   PubMed Web of Science ®Google Scholar
• Seifter J L., Aronson P S. Properties and physiologic roles of the plasma membrane sodium-hydrogen exchanger. J Clin Invest 1986; 78: 859–64
   PubMed Web of Science ®Google Scholar
• Morgan D B., Stewart A D., Davidson C. Relations between erythrocyte lithium efflux, blood pressure and family histories of hypertension and cardiovascular disease: studies in a factory workforce and hypertension clinic. J Hypertens 1986; 4: 609–15
   Google Scholar
• Carr S J., Thomas T H., Wilkinson R. Erythrocyte sodium-lithium countertransport in primary and renal hypertension: relation to family history. Eur J Clin Invest 1989; 19: 101–6
   PubMedGoogle Scholar
• Seaquist E R., Goetz F C., Rich S, Barbosa J. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989; 320: 1161–5
   PubMed Web of Science ®Google Scholar
• Kofoed-Enevoldsen A. Inhibition of glomerular glucos-aminyl N-deacetylase in diabetic rats. Kidney Int 1992; 41: 763–7
   PubMedGoogle Scholar
• Spurr N K., Gough A C., Gosden J, et al. Restriction fragment length polymorphism analysis and assignment of the metalloproteinases stomelysin and collagenase to the long arm of chromosome 11. Genomics 1988; 2: 119–27
   Google Scholar
• Bogardus C, Lillioja S, Nyomba B L., et al. Distribution of in vivo insulin action in Pima Indians a mixture of three normal distributions. Diabetes 1989; 39: 1423–32
   Google Scholar
• Gall M-A, Rossing P, Skøtt P, et al. Prevalence of micro-and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 655–61
   PubMed Web of Science ®Google Scholar
• Gould M M., Mohamed-Ali V, Goubet S A., Yudkin J S., Haines A P. Microalbuminuria in non-diabetic subjects—associations with blood-glucose, blood pressure and deprivation? Diabetic Med 1992; 9(Suppl 1)P102
   Google Scholar
• Kuh D, Wadsworth M. Parental height: childhood environment and subsequent adult height in a natural birth cohort. Int J Epidemiol 1989; 18: 663–8
   PubMed Web of Science ®Google Scholar
• Barker D JP, Winter P D., Osmond C, Margetts B, Simmonds S J. Weight in infancy and death from ischaemic heart disease. Lancet 1989; ii: 577–80
   Google Scholar
• Hales C N., Barker D JP, Clark P MS, Cox L J., Fall C, Osmond C, Winter P D. Fetal and infant growth and impaired glucose tolerance at age 64. Br Med J 1991; 303: 1019–22
   PubMed Web of Science ®Google Scholar
• Barker D JP, Meade T W., Fall C HD, Lee A, Osmond C, Phipps K, Stirling Y. Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life. Br Med J 1992; 304: 148–52
   PubMed Web of Science ®Google Scholar
• Barker D JP, Martyn C N. The maternal and fetal origins of cardiovascular disease. J Epidemiol Community Health 1992; 46: 8–11
   PubMed Web of Science ®Google Scholar